Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (235)

« Back to Publications

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Altaf M. et al, (2026)

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Fumagalli MJ. et al, (2025)

Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.

Mellors J. et al, (2025), Nat Commun, 16

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Gunst JD. et al, (2025), Nat Commun, 16

MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.

Dolton G. et al, (2025), J Clin Invest, 135

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.

Sun W. et al, (2024), J Exp Med, 221

Impact of antiretroviral therapy during primary HIV infection on T-cell immunity after treatment interruption.

Tipoe T. et al, (2024), Eur J Immunol, 54

Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning.

Igiraneza AB. et al, (2024), PLoS Comput Biol, 20

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies

Gunst J. et al, (2024)

Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery.

Ali M. et al, (2024), Clin Exp Immunol, 218, 78 - 92

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.

Alagaratnam J. et al, (2024), J Virus Erad, 10

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Thornhill JP. et al, (2024), AIDS, 38, 679 - 688

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.

Nel C. and Frater J., (2024), Front Immunol, 15

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.

Zacharopoulou P. et al, (2024), Front Immunol, 15

Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.

Sampson OL. et al, (2024), Front Immunol, 15

Load More

1
2
3
4
5
6
7
...
»